Effects of the 2-ethylthiobenzimidazole hydrobromide (bemithyl) on carbohydrate metabolism in cirrhotic rat liver.
Kudryavtseva MV, Bezborodkina NN, Okovity SV, Kudryavtsey BN · 2003 · Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie; 2003 Mar
Study findings
In cirrhotic rat liver, bemithyl reduced glycogen content and altered glycogen-related enzyme activity. These are metabolic findings rather than clinical liver outcomes.
- Population and setting
- Experimental animals or tissue preparations
- Evidence type
- Animal / experimental
- Preparation
- See the original report; formulation details require verification.
- Source language
- eng
- Title source
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
Study limitations
- Full text and detailed methods have not been independently assessed.
- Experimental or incompletely specified settings do not establish human efficacy, dosing or safety.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Indexed citation and English abstract checked.
Recorded source-check date: 2026-10-07. This date does not imply a completed systematic review.
Citation and original source
Original source: Kudryavtseva MV, Bezborodkina NN, Okovity SV, Kudryavtsey BN. Effects of the 2-ethylthiobenzimidazole hydrobromide (bemithyl) on carbohydrate metabolism in cirrhotic rat liver. Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie; 2003 Mar 2003.
Molekul research summary: https://molekul.io/research/bemitil-extra-12710718. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry